Patents by Inventor Jorn Gorlach

Jorn Gorlach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9588114
    Abstract: A device for performing immunoassays on analytes is provided. The device includes an immunosorbent membrane, an absorbent material, a piston component located below said absorbent material to draw analytes in a sample through the immunosorbent membrane into the absorbent material, and discrete groups of pressure-sensitive microcapsules located on the immunosorbent membrane.
    Type: Grant
    Filed: April 23, 2014
    Date of Patent: March 7, 2017
    Assignee: MONTECITO BIO SCIENCES LTD
    Inventors: Edward W. Withrow, III, Jorn Gorlach
  • Patent number: 9573990
    Abstract: The present invention relates to a method for producing high affinity antibodies that are antigen-specific. The method involves binding a plurality of antibody-producing B-cells from a mammal to a plurality of cognate antigens; sorting the bound antibody-producing B-cell and cognate antigen; amplifying nucleic acid sequences encoding each antibody, or fragment thereof, from the B-cells; and expressing the each antibody in a protein expression system. Antibodies produced in this manner are useful in diagnostic and therapeutic applications.
    Type: Grant
    Filed: October 5, 2011
    Date of Patent: February 21, 2017
    Assignee: MONTECITO BIO-SCIENCES, LTD.
    Inventor: Jorn Gorlach
  • Publication number: 20160084831
    Abstract: A device for performing immunoassays on analytes is provided. The device includes an immunosorbent membrane, an absorbent material, a piston component located below said absorbent material to draw analytes in a sample through the immunosorbent membrane into the absorbent material, and discrete groups of pressure-sensitive microcapsules located on the immunosorbent membrane.
    Type: Application
    Filed: April 23, 2014
    Publication date: March 24, 2016
    Inventors: Edward W. Withrow, III, Jorn Gorlach
  • Patent number: 9170258
    Abstract: The present invention is an improved apparatus for sample analysis. The apparatus employs an assay component containing a membrane having one or a plurality of analyte-specific binding agents attached thereto, a means for absorbing liquid, and a piston means for drawing analytes through said membrane into said means for absorbing liquid. The apparatus is configured to be portable and provide a detector for detecting binding of an analyte to an analyte-specific binding agent, a plurality of data acquisition components, and a computer for integrating, analyzing and storing the detected analyte specific binding and acquired data.
    Type: Grant
    Filed: November 25, 2014
    Date of Patent: October 27, 2015
    Assignee: Montecito Bio Sciences, Ltd.
    Inventors: Edward W. Withrow, III, Jorn Gorlach
  • Publication number: 20150072403
    Abstract: The present invention is an improved apparatus for sample analysis. The apparatus employs an assay component containing a membrane having one or a plurality of analyte-specific binding agents attached thereto, a means for absorbing liquid, and a piston means for drawing analytes through said membrane into said means for absorbing liquid. The apparatus is configured to be portable and provide a detector for detecting binding of an analyte to an analyte-specific binding agent, a plurality of data acquisition components, and a computer for integrating, analyzing and storing the detected analyte specific binding and acquired data.
    Type: Application
    Filed: November 25, 2014
    Publication date: March 12, 2015
    Inventors: Edward W. Withrow, III, Jorn Gorlach
  • Publication number: 20150011418
    Abstract: The present invention is a method for using levels of soluble Clusters of Differentiation (CD) proteins, or cell surface-localized CD proteins extracted from T lymphocytes for determining the immune status of a subject. The present invention also a kit containing a CD protein extraction means and at least one antibody which specifically binds a CD protein for use in carrying out the method of the invention.
    Type: Application
    Filed: September 22, 2014
    Publication date: January 8, 2015
    Inventors: Jorn Gorlach, Jenifer Marie Gorlach
  • Patent number: 8920725
    Abstract: The present invention is an improved apparatus for sample analysis. The apparatus employs an assay component containing a membrane having one or a plurality of analyte-specific binding agents attached thereto, a means for absorbing liquid, and a piston means for drawing analytes through said membrane into said means for absorbing liquid. The apparatus is configured to be portable and provide a detector for detecting binding of an analyte to an analyte-specific binding agent, a plurality of data acquisition components, and a computer for integrating, analyzing and storing the detected analyte specific binding and acquired data.
    Type: Grant
    Filed: September 29, 2011
    Date of Patent: December 30, 2014
    Assignee: Montecito Bio-Sciences, Ltd.
    Inventors: Edward W. Withrow, III, Jorn Gorlach
  • Publication number: 20120029171
    Abstract: The present invention relates to a method for producing high affinity antibodies that are antigen-specific. The method involves binding a plurality of antibody-producing B-cells from a mammal to a plurality of cognate antigens; sorting the bound antibody-producing B-cell and cognate antigen; amplifying nucleic acid sequences encoding each antibody, or fragment thereof, from the B-cells; and expressing the each antibody in a protein expression system. Antibodies produced in this manner are useful in diagnostic and therapeutic applications.
    Type: Application
    Filed: October 5, 2011
    Publication date: February 2, 2012
    Applicant: Montecito Bio-Sciences, Ltd.
    Inventor: Jorn Gorlach
  • Publication number: 20120020837
    Abstract: The present invention is an improved apparatus for sample analysis. The apparatus employs an assay component containing a membrane having one or a plurality of analyte-specific binding agents attached thereto, a means for absorbing liquid, and a piston means for drawing analytes through said membrane into said means for absorbing liquid. The apparatus is configured to be portable and provide a detector for detecting binding of an analyte to an analyte-specific binding agent, a plurality of data acquisition components, and a computer for integrating, analyzing and storing the detected analyte specific binding and acquired data.
    Type: Application
    Filed: September 29, 2011
    Publication date: January 26, 2012
    Applicant: Montecito Bio-Sciences, Ltd.
    Inventors: Edward W. Withrow, III, Jorn Gorlach
  • Publication number: 20110174133
    Abstract: The present invention features a headstock which changes the tonal quality of a stringed instrument. Specifically, the headstock of this invention contains one or more slots thereby generating independently resonating arms to which the strings are anchored. In this regard, the resonance of the string is dependent upon the resonance of the arm.
    Type: Application
    Filed: January 14, 2011
    Publication date: July 21, 2011
    Inventors: Paul Unkert, Jorn Gorlach
  • Publication number: 20100210824
    Abstract: The present invention relates to a method for identifying a binding agent or epitope for use in drug design, drug targeting or diagnostics. The method employs contacting and sorting binding agents and cognate epitopes from collections thereof, characterizing the binding agent and cognate epitope, detecting the level or location of the epitope in a sample using the binding agent, and correlating the level or location of the epitope in the sample with the presence or stage of a disease or condition to identify novel drugs, targeting moieties, or diagnostic agents.
    Type: Application
    Filed: April 28, 2010
    Publication date: August 19, 2010
    Inventor: Jorn Gorlach
  • Publication number: 20090010804
    Abstract: The present invention is an improved apparatus for sample analysis. The apparatus employs an assay component containing a membrane having one or a plurality of analyte-specific binding agents attached thereto, a means for absorbing liquid, and a piston means for drawing analytes through said membrane into said means for absorbing liquid. The apparatus is configured to be portable and provide a detector for detecting binding of an analyte to an analyte-specific binding agent, a plurality of data acquisition components, and a computer for integrating, analyzing and storing the detected analyte specific binding and acquired data.
    Type: Application
    Filed: October 25, 2007
    Publication date: January 8, 2009
    Inventors: Edward W. Withrow, III, Jorn Gorlach
  • Publication number: 20080085532
    Abstract: The present invention is a method for using levels of soluble Clusters of Differentiation (CD) proteins, or cell surface-localized CD proteins extracted from T lymphocytes for determining the immune status of a subject. The present invention also a kit containing a CD protein extraction means and at least one antibody which specifically binds a CD protein for use in carrying out the method of the invention.
    Type: Application
    Filed: September 18, 2007
    Publication date: April 10, 2008
    Inventors: Jorn Gorlach, Jenifer Gorlach
  • Publication number: 20060052948
    Abstract: The present invention relates to a method for identifying a binding agent or epitope for use in drug design, drug targeting or diagnostics. The method employs contacting and sorting binding agents and cognate epitopes from collections thereof, characterizing the binding agent and cognate epitope, detecting the level or location of the epitope in a sample using the binding agent, and correlating the level or location of the epitope in the sample with the presence or stage of a disease or condition to identify novel drugs, targeting moieties, or diagnostic agents.
    Type: Application
    Filed: September 7, 2005
    Publication date: March 9, 2006
    Inventor: Jorn Gorlach
  • Publication number: 20060051348
    Abstract: The present invention relates to a method for producing high affinity antibodies that are antigen-specific. The method involves binding a plurality of antibody-producing B-cells from a mammal to a plurality of cognate antigens; sorting the bound antibody-producing B-cell and cognate antigen; amplifying nucleic acid sequences encoding each antibody, or fragment thereof, from the B-cells; and expressing the each antibody in a protein expression system. Antibodies produced in this manner are useful in diagnostic and therapeutic applications.
    Type: Application
    Filed: September 7, 2005
    Publication date: March 9, 2006
    Inventor: Jorn Gorlach
  • Publication number: 20050112715
    Abstract: The present inventors have discovered that pectin esterase is essential for plant growth. Specifically, the inhibition of pectin esterase gene expression resulted in seedlings that were damaged, short, and stunted at a very early growth stage. Thus, pectin esterase can be used as a target for the identification of herbicides. Accordingly, the present invention provides methods for the identification of compounds that inhibit pectin esterase expression or activity, comprising: contacting a compound with a pectin esterase and detecting the presence and/or absence of binding between said compound and said pectin esterase, or detecting a decrease in pectin esterase expression or activity. The methods of the invention are useful for the identification of herbicides.
    Type: Application
    Filed: November 20, 2003
    Publication date: May 26, 2005
    Inventors: Adel Zayed, Robert Ascenzi, Douglas Boyes, Rao Mulpuri, Neil Hoffman, Keith Davis, Jorn Gorlach, Jeffrey Woessner, Carol Hamilton, Kenneth Phillips
  • Publication number: 20050101485
    Abstract: The present inventors have discovered that Biotin synthase (BS) is essential for plant growth. Specifically, inhibition of BS gene expression in plant seedlings results in severe chlorosis and reduced growth. Thus, BS can be used as a target for the identification of herbicides. Accordingly, the present invention provides methods for the identification of compounds that inhibit BS expression or activity, and as such, the methods of the invention are useful for the identification of herbicides.
    Type: Application
    Filed: November 6, 2003
    Publication date: May 12, 2005
    Inventors: Neil Hoffman, Jorn Gorlach, Douglas Boyes, Adel Zayed, Jeffrey Woessner, Carol Hamilton, Keith Davis, Robert Ascenzi
  • Publication number: 20050100879
    Abstract: The present inventors have discovered that Flavanone 3-hydroxylase (“FHT”) is essential for plant growth. Specifically, the inhibition of FHT gene expression in plant seedlings results in small and chlorotic seedlings. Thus, FHT can be used as a target for the identification of herbicides. Accordingly, the present invention provides methods for the identification of compounds that inhibit FHT expression or activity. The present invention can be used to identify compounds having herbicide activity by contacting a compound with FHT and detecting the presence and/or absence of binding between the compound and the FHT, or alternatively, detecting a decrease in FHT expression or activity.
    Type: Application
    Filed: November 6, 2003
    Publication date: May 12, 2005
    Inventors: Keith Davis, Adel Zayed, Robert Ascenzi, Douglas Boyes, Neil Hoffman, Jorn Gorlach, Jeffrey Woessner, Carol Hamilton, Kenneth Phillips
  • Patent number: 6858404
    Abstract: Nucleic acid molecules are isolated from Sorangium cellulosum that encode polypeptides necessary for the biosynthesis of epothilone. Disclosed are methods for the production of epothilone in recombinant hosts transformed with the genes of the invention. In this manner, epothilone can be produced in quantities large enough to enable their purification and use in pharmaceutical formulations such as those for the treatment of cancer.
    Type: Grant
    Filed: November 13, 2001
    Date of Patent: February 22, 2005
    Assignee: Novartis AG
    Inventors: Thomas Schupp, James Madison Ligon, Istvan Molnar, Ross Zirkle, Devon Dawn Cyr, Jörn Görlach
  • Publication number: 20040265836
    Abstract: The present inventors have discovered that LCBH is essential for plant growth. Specifically, the inhibition of LCBH gene expression in Arabidopsis results in reduced growth and abnormal development. Thus, LCBH is useful as a target for the identification of herbicides. Accordingly, the present invention provides methods for the identification of herbicides by measuring the activity of a LCBH in the presence and absence of a compound, where an alteration of LCBH activity in the presence of the compound indicates the compound as a candidate for a herbicide.
    Type: Application
    Filed: June 30, 2003
    Publication date: December 30, 2004
    Inventors: M. DeZwaan Todd, Lining Guo, Keith Davis, Adel Zayed, Susanne Kjemtrup, Douglas Boyes, Brenda Warrick, Joseph Cameron Mitchell, Robert Ascenzi, Carol Hamilton, Jeffrey Woessner, Jorn Gorlach, Neil Hoffman, Rao Mulpuri